e-learning
resources
Stockholm 2002
Sunday 15.09.2002
High altitude and hypoxia
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
State of β-adrenoreceptors in pulmonary hypertension due to COPD at high altitude
A. S. Sarybaev, I. S. Sabirov, A. S. Sydykov, A. A. Aldashev, T. Y. Murzapayazova, M. M. Mirrakhimov (Bishkek, Kyrgyzstan)
Source:
Annual Congress 2002 - High altitude and hypoxia
Session:
High altitude and hypoxia
Session type:
Thematic Poster Session
Number:
694
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. S. Sarybaev, I. S. Sabirov, A. S. Sydykov, A. A. Aldashev, T. Y. Murzapayazova, M. M. Mirrakhimov (Bishkek, Kyrgyzstan). State of β-adrenoreceptors in pulmonary hypertension due to COPD at high altitude. Eur Respir J 2002; 20: Suppl. 38, 694
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
The definition of pulmonary hypertension: history, practical implications and current controversies
Related content which might interest you:
Pulmonary hypertension due to COPD at high altitude
Source: Eur Respir J 2002; 20: Suppl. 38, 99s
Year: 2002
High-altitude disease
Source: Respipedia Article
Year: 2017
COPD and asthma patients: what can they expect of high altitude residences?
Source: Annual Congress 2006 - Man at altitude: benefits and risks of pre-existing respiratory impairment due to various diseases
Year: 2006
Endothelin and high altitude pulmonary hypertension
Source: Annual Congress 2008 - Pulmonary arterial hypertension and other pulmonary vascular diseases
Year: 2008
Higher pulmonary artery pressure in children than in adults upon fast ascent to high altitude
Source: Eur Respir J 2008; 32: 664-669
Year: 2008
Prevalence of established and exercise induced pulmonary hypertension in COPD
Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease
Year: 2011
Right and left ventricular function in lowlanders with COPD travelling to moderate altitude
Source: International Congress 2015 – Pulmonary hypertension in lung disease
Year: 2015
The prevalence and characteristics of pulmonary hypertension in severe COPD
Source: International Congress 2016 – Pulmonary hypertension in lung disease
Year: 2016
Calcium channel activity in lowlanders and in highlanders with pulmonary hypertension due to chronic obstructive pulmonary disease
Source: Eur Respir J 2002; 20: Suppl. 38, 99s
Year: 2002
Pulmonary hemodynamics in highlanders with high altitude pulmonary hypertension in 1 year after finishing of sildenafil treatment
Source: Annual Congress 2005 - Pulmonary arterial hypertension diagnosis and therapy
Year: 2005
Common genetic basis for pulmonary arterial hypertension and high altitude pulmonary edema
Source: International Congress 2018 – Experimental research in pulmonary hypertension
Year: 2018
Cerebral oxygenation in highlanders with high altitude pulmonary hypertension
Source: Annual Congress 2013 –Clinical physiology and functional imaging in health and disease
Year: 2013
Pulmonary hypertension, and exercise tolerance in patients with COPD exacerbation
Source: Annual Congress 2010 - Pulmonary circulation: clinical aspects
Year: 2010
Effects of sildenafil on secondary pulmonary hypertension in highlanders with COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 73s
Year: 2007
Travel to high altitude with pre-existing lung disease
Source: Eur Respir J 2007; 29: 770-792
Year: 2007
Cognitive performance in patients with chronic obstructive pulmonary disease at moderate altitude
Source: Annual Congress 2010 - Advances in lung function II
Year: 2010
Estimation of right ventricular function in highlanders with high altitude pulmonary hypertension and high altitude cor pulmonale
Source: Annual Congress 2011 - Physiology of human pulmonary hypertension
Year: 2011
Right ventricular function in highlanders with high altitude pulmonary hypertension and high altitude cor pulmonale
Source: Annual Congress 2010 - Pulmonary circulation: clinical aspects
Year: 2010
Co-morbidities and pulmonary arterial hypertension (PAH) in COPD patients
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016
Rating predominance of pulmonary hypertension, lung hyperinflation and left ventricular dysfunction in patients with moderate and severe COPD in Belarus
Source: International Congress 2015 – Pulmonary hypertension in lung disease
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept